Routine proxy reminder — no trading signal. Monitor for any dissident activity or vote results post-June 17 meeting. The officer exculpation amendment is standard governance but could see opposition from governance-focused investors.
Price Chart
Executive Summary
Caribou Biosciences filed a DEFA14A urging stockholders to vote ahead of the June 17, 2026 annual meeting. The board recommends voting FOR director elections, auditor ratification, an officer exculpation charter amendment, and an adjournment proposal. This is a routine solicitation reminder with no new financial or strategic information.
Key Facts
- Annual meeting scheduled for June 17, 2026
- Board recommends voting FOR all four proposals: Class II director election, Deloitte ratification, officer exculpation amendment, and adjournment proposal
- Filing is a reminder to vote — no new material information disclosed
- D.F. King & Co. assisting with proxy solicitation
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- Low shareholder turnout could delay or fail the officer exculpation proposal
- No dissident or activist context in this filing — risk of unexpected opposition is minimal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001619856-26-000039 |
| Document: 0001619856-26-000039-index-headers.html | 0001619856-26-000039 |
| Document: 0001619856-26-000039-index.html | 0001619856-26-000039 |
| Document: 0001619856-26-000039.txt | 0001619856-26-000039 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 16w ago | 8-K | $1.66 $1.94 | ▲ +16.87% | ▲ +14.98% | $1.23 (−26.20%) |
Jun 11, 2026 16w ago | Press Release | $1.66 $1.94 | ▲ +16.87% | ▲ +14.98% | $1.23 (−26.20%) |
Jun 5, 2026 16w ago | DEFA14A | $1.84 $1.83 | ▼ −0.54% | ▼ −2.17% | $1.23 (−33.42%) |
Apr 24, 2026 22w ago | DEFA14A | $2.13 $2.16 | ▲ +1.41% | ▼ −3.55% | $1.23 (−42.49%) |
Mar 5, 2026 30w ago | 8-K | $1.82 $1.95 | ▲ +7.14% | ▲ +9.19% | $1.23 (−32.69%) |
Mar 5, 2026 30w ago | Press Release | $1.82 $1.95 | ▲ +7.14% | ▲ +9.19% | $1.23 (−32.69%) |
Feb 28, 2026 30w ago | Institutional Cluster | $1.84 $1.72 | ▼ −6.52% | ▲ +1.42% | $1.23 (−33.42%) |
Feb 24, 2026 31w ago | Insider Cluster | $2.14 $1.82 | ▼ −14.95% | ▼ −9.97% | $1.23 (−42.76%) |
Feb 24, 2026 31w ago | Insider Cluster | $2.14 $1.82 | ▼ −14.95% | ▼ −9.97% | $1.23 (−42.76%) |
Feb 24, 2026 31w ago | Insider Cluster | $2.14 $1.82 | ▼ −14.95% | ▼ −9.97% | $1.23 (−42.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access